Clinical Benefit of Topoisomerase Downregulation

计划入组 15 人 · 首次发布于 2005 年 11 月 7 日

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

计划入组 40 人 · 首次发布于 2026 年 2 月 18 日

Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin

计划入组 338 人 · 首次发布于 2005 年 9 月 13 日

Tanshinone IIA

NMMHC IIA Inhibitors

Topoisomerase inhibitor (Idorsia)

Fox Ira

Israel

INA RESPOND

Indonesia

ADENTA SIA

Latvia

Cosmos Health Acquires Rights to Two Patented Anticancer Drugs Targeting Multiple Cancers

Tubulis' ADC TUB-030 Enters Phase I/IIa Trial for Advanced Solid Tumors

FDA Clears IND Application for Zymeworks' Novel FRα-Targeted ADC, ZW191